Women are disproportionately affected by Alzheimer's disease (AD) in terms of both disease
prevalence and severity. Previous autopsy work has suggested that, in the presence of AD …

Sex differences in Alzheimer's disease (AD) biology and progression are not yet fully
characterized. The goal of this study is to examine the effect of sex on cognitive progression …

Multiple studies suggest that females are affected by Alzheimer disease (AD) more severely
and more frequently than males. Other studies have failed to confirm this and the issue …

There is a growing recognition of sex differences in Alzheimer's disease (AD). Females
show an advantage over males on tests of verbal memory, which are used to diagnose AD …

Two thirds of all persons with late-onset Alzheimer's disease (AD) are women. Identification
of sex-based molecular mechanisms underpinning the female-based prevalence of AD …

Alzheimer's disease (AD) includes a long asymptomatic stage, which precedes the formal
diagnosis of dementia. AD biomarker models provide a framework for precision medicine …

Introduction Observational multimodal neuroimaging studies indicate sex differences in
Alzheimer's disease pathophysiological markers. Methods Positron emission tomography …

Alzheimer's dementia is significantly more common in women than in men. However, few
pathological studies have addressed sex difference in Alzheimer's disease (AD) and other …

Sex biology influences Alzheimer's disease (AD). Sex differences exist in the epidemiologic,
imaging, biomarker, and pathology studies of this uniquely human condition. The mandate …

Objective Women have a higher lifetime risk of Alzheimer's disease (AD) than men. Among
cognitively normal (CN) older adults, women exhibit elevated tau positron emission …